Clinical Trial Update: Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ruxolitinib cream for facial/neck involvement in atopic dermatitis; the trial has completed and results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2024-08-15